企業プロフィール
OmniAb 株価・ニュース・カタリスト
- ティッカー:
- OABI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.30 USD (+2.63%)
終値
最終更新: 2026年8月20日
380M USD
時価総額
株価変動の要因
As of Aug 20, 2026, OABI closed up 2.63% at $4.30. No new same-company headline was identified in the current news window.
企業概要
事業概要
OmniAb is a biotechnology platform company that monetizes antibody discovery technology through partnerships and licensing. It provides tools and engineered animal platforms to discover therapeutic antibodies.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, OmniAb sits in biotech infrastructure and discovery platforms.
ビジネスモデルの特徴
Revenue depends on partner demand, technology adoption, and the economics of platform licensing rather than direct drug sales.
バイオ業界での位置付け
OmniAb is an enabling antibody-platform name whose value comes from discovery infrastructure and partnership monetization.
今後のカタリスト
- OmniAb’s catalysts are partner-program milestones, royalty or milestone revenue, and whether the antibody-discovery platform keeps producing value across partners. The market will care about utilization and downstream optionality more than a single headline.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。